StAbilize™

against antibody aggregation

Partnering

Solvanix works with the biotech and pharma industries developing therapeutic antibodies by:

  • Service Offering

    Solvanix provides services to clients under which we provide fully human binding domain sequences using the StAbilize™ technology. These binding domains incorporating the StAbilize™ technology are fully tested for both thermal stability and antigen binding.

  • Commercial Licenses

    Non-exclusive licenses are available for the StAbilize™ technology.